{"id":17164,"date":"2026-01-11T22:36:04","date_gmt":"2026-01-11T13:36:04","guid":{"rendered":"https:\/\/japanir.jp\/en\/company\/company-4886\/"},"modified":"2026-08-23T13:40:38","modified_gmt":"2026-08-23T04:40:38","slug":"company-4886","status":"publish","type":"company","link":"https:\/\/japanir.jp\/en\/company\/company-4886\/","title":{"rendered":"ASKA PHARMACEUTICAL HOLDINGS CO"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"4886","DATE":"2026-01-09","longName":"ASKA Pharmaceutical Holdings Co.,Ltd.","company_name_ja":"","fullTimeEmployees":1611,"address":"","phone":"","website":"https:\/\/www.aska-pharma-hd.co.jp","industry":"Drug Manufacturers - Specialty & Generic","sector":"Healthcare","regularMarketPrice":2101,"financialCurrency":"","marketCap":59660,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":191.12,"epsForward":0,"bookValue":0,"totalRevenue":71127000000,"OperatingIncome":5834000000,"operatingMargins":8.1999999999999993,"NetIncome":5424000000,"profitMargins":7.6299999999999999,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":7.71,"recommendationMean":3,"recommendationKey":"none","targetMeanPrice":2400,"numberOfAnalystOpinions":1,"analyst_earnings_data":"{\"success\": true, \"fetched_at\": \"2026-08-01T04:32:32.435000\", \"ticker\": \"4886\", \"ticker_full\": \"4886.T\", \"company_name\": \"ASKA PHARMACEUTICAL HOLDINGS CO\", \"analyst_recommendations\": {\"has_data\": true, \"period\": \"1\", \"strong_buy\": 0, \"buy\": 0, \"hold\": 1, \"sell\": 0, \"strong_sell\": 0, \"total_analysts\": 1, \"recommendation_key\": \"none\", \"recommendation_mean\": null}, \"target_prices\": {\"has_data\": true, \"current\": 2151.0, \"high\": 2400.0, \"low\": 2400.0, \"mean\": 2400.0, \"median\": 2400.0}, \"earnings_dates\": {\"has_data\": true, \"next_earnings\": null, \"future_count\": 0, \"past_earnings\": [{\"date\": \"2024-08-04\", \"eps_estimate\": 43.8, \"eps_actual\": 44.95, \"surprise_pct\": 2.63}, {\"date\": \"2016-02-03\", \"eps_estimate\": 29.16, \"eps_actual\": 24.54, \"surprise_pct\": -15.86}, {\"date\": \"2015-08-02\", \"eps_estimate\": 24.26, \"eps_actual\": 6.72, \"surprise_pct\": -72.3}, {\"date\": \"2015-05-11\", \"eps_estimate\": -12.19, \"eps_actual\": -10.37, \"surprise_pct\": 14.92}, {\"date\": \"2015-02-03\", \"eps_estimate\": 22.7, \"eps_actual\": 23.21, \"surprise_pct\": 2.25}]}, \"shareholders\": {\"has_data\": true, \"insider_pct\": 24.86, \"institution_pct\": 33.64, \"major_holders\": [{\"label\": \"\", \"value\": 24.86}, {\"label\": \"\", \"value\": 33.64}, {\"label\": \"\", \"value\": 44.76}, {\"label\": \"\", \"value\": 34.0}], \"institutional_holders\": [{\"holder\": \"DFA International Small Cap Value Portfolio\", \"shares\": 353200, \"date_reported\": \"2023-10-31\", \"pct_held\": 1.16, \"pct_change\": 2.29, \"value\": 759733200}, {\"holder\": \"Vanguard International Stock Index-Total Intl Stock Indx\", \"shares\": 207933, \"date_reported\": \"2023-10-31\", \"pct_held\": 0.68, \"pct_change\": 0.0, \"value\": 447263883}, {\"holder\": \"Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund\", \"shares\": 177205, \"date_reported\": \"2023-09-30\", \"pct_held\": 0.58, \"pct_change\": 14.17, \"value\": 381167955}, {\"holder\": \"DFA Japanese Small Company Series\", \"shares\": 130700, \"date_reported\": \"2023-10-31\", \"pct_held\": 0.43, \"pct_change\": 0.0, \"value\": 281135700}, {\"holder\": \"DFA International Core Equity Portfolio\", \"shares\": 125900, \"date_reported\": \"2023-10-31\", \"pct_held\": 0.41, \"pct_change\": 0.0, \"value\": 270810900}, {\"holder\": \"Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index\", \"shares\": 67800, \"date_reported\": \"2023-10-31\", \"pct_held\": 0.22, \"pct_change\": 0.0, \"value\": 145837800}, {\"holder\": \"Mercer Non-U.S. Core Equity Fd\", \"shares\": 67900, \"date_reported\": \"2023-12-31\", \"pct_held\": 0.22, \"pct_change\": 0.0, \"value\": 146052900}, {\"holder\": \"Schwab Strategic Tr-Schwab International Small Cap Equity ETF\", \"shares\": 40463, \"date_reported\": \"2023-11-30\", \"pct_held\": 0.13, \"pct_change\": 2.48, \"value\": 87035913}, {\"holder\": \"DFA International Vector Equity Port\", \"shares\": 24000, \"date_reported\": \"2023-10-31\", \"pct_held\": 0.08, \"pct_change\": 0.0, \"value\": 51624000}, {\"holder\": \"Vanguard International Stock Index-Pacific Stock Index\", \"shares\": 22204, \"date_reported\": \"2023-10-31\", \"pct_held\": 0.07, \"pct_change\": 0.0, \"value\": 47760804}], \"mutualfund_holders\": []}}","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of internal medicine, obstetrics and gynecology, and urology; and research, manufactures, imports, exports, and sells veterinary medicines and medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; engages in the manufacturing, sales, import, and distribution of prescription drugs, over-the-counter drugs, health foods, and other products; and offers quasi-drugs, food supplements, and medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":33,"get_dividend_history_year2":57,"get_dividend_history_year3":45,"get_dividend_history_year4":28,"get_dividend_history_year5":16,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-08-23T02:39:59.956976\", \"ticker\": \"4886\", \"ticker_full\": \"4886.T\", \"company_name\": \"ASKA PHARMACEUTICAL HOLDINGS CO\", \"company_info\": {\"name_en\": \"ASKA PHARMACEUTICAL HOLDINGS CO\", \"long_name\": \"ASKA Pharmaceutical Holdings Co.,Ltd.\", \"sector\": \"Healthcare\", \"industry\": \"Drug Manufacturers - Specialty & Generic\", \"website\": \"https:\/\/www.aska-pharma-hd.co.jp\", \"employees\": 1611, \"country\": \"Japan\", \"city\": \"Tokyo\", \"address\": \"5-1, Shibaura 2-Chome\", \"description\": \"ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of internal medicine, obstetrics and gynecology, and urology; and research, manufactures, imports, exports, and sells veterinary medicines and medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; engages in the manufacturing, sales, import, and distribution of prescription drugs, over-the-counter drugs, health foods, and other products; and offers quasi-drugs, food supplements, and medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 2179.2, \"deviation\": -0.42, \"trend\": \"down\"}, \"ma_25\": {\"ma_value\": 2155.48, \"deviation\": 0.67, \"trend\": \"up\"}, \"ma_75\": {\"ma_value\": 2414.41, \"deviation\": -10.12, \"trend\": \"down\"}, \"ma_200\": {\"ma_value\": 2318.91, \"deviation\": -6.42, \"trend\": \"down\"}}, \"financials\": {\"years\": [{\"year\": 2026, \"revenue\": 71127000000.0, \"revenue_fmt\": \"\u00a5711\u5104\", \"gross_profit\": 34145000000.0, \"gross_profit_fmt\": \"\u00a5341\u5104\", \"operating_income\": 5834000000.0, \"operating_income_fmt\": \"\u00a558\u5104\", \"ebit\": 7213000000.0, \"ebit_fmt\": \"\u00a572\u5104\", \"net_income\": 5424000000.0, \"net_income_fmt\": \"\u00a554\u5104\", \"eps\": 191.12, \"operating_margin\": 8.2, \"total_assets\": 112379000000.0, \"total_assets_fmt\": \"\u00a51124\u5104\", \"total_equity\": 70359000000.0, \"total_equity_fmt\": \"\u00a5704\u5104\", \"total_debt\": 11434000000.0, \"total_debt_fmt\": \"\u00a5114\u5104\", \"total_cash\": 10126000000.0, \"total_cash_fmt\": \"\u00a5101\u5104\", \"equity_ratio\": 62.61, \"de_ratio\": 0.16, \"current_ratio\": 2.76, \"operating_cf\": 6303000000.0, \"operating_cf_fmt\": \"\u00a563\u5104\", \"investing_cf\": -5752000000.0, \"investing_cf_fmt\": \"-\u00a558\u5104\", \"financing_cf\": -818000000.0, \"financing_cf_fmt\": \"-\u00a58\u5104\", \"free_cf\": 3429000000.0, \"free_cf_fmt\": \"\u00a534\u5104\", \"net_margin\": 7.63, \"roe\": 7.71, \"roa\": 4.83}, {\"year\": 2025, \"revenue\": 64139000000.0, \"revenue_fmt\": \"\u00a5641\u5104\", \"gross_profit\": 31335000000.0, \"gross_profit_fmt\": \"\u00a5313\u5104\", \"operating_income\": 5332000000.0, \"operating_income_fmt\": \"\u00a553\u5104\", \"ebit\": 6243000000.0, \"ebit_fmt\": \"\u00a562\u5104\", \"net_income\": 5101000000.0, \"net_income_fmt\": \"\u00a551\u5104\", \"eps\": 179.95, \"operating_margin\": 8.31, \"total_assets\": 104295000000.0, \"total_assets_fmt\": \"\u00a51043\u5104\", \"total_equity\": 65309000000.0, \"total_equity_fmt\": \"\u00a5653\u5104\", \"total_debt\": 10902000000.0, \"total_debt_fmt\": \"\u00a5109\u5104\", \"total_cash\": 10603000000.0, \"total_cash_fmt\": \"\u00a5106\u5104\", \"equity_ratio\": 62.62, \"de_ratio\": 0.17, \"current_ratio\": 2.55, \"operating_cf\": 2485000000.0, \"operating_cf_fmt\": \"\u00a525\u5104\", \"investing_cf\": -6124000000.0, \"investing_cf_fmt\": \"-\u00a561\u5104\", \"financing_cf\": -2956000000.0, \"financing_cf_fmt\": \"-\u00a530\u5104\", \"free_cf\": -1077000000.0, \"free_cf_fmt\": \"-\u00a511\u5104\", \"net_margin\": 7.95, \"roe\": 7.81, \"roa\": 4.89}, {\"year\": 2024, \"revenue\": 62843000000.0, \"revenue_fmt\": \"\u00a5628\u5104\", \"gross_profit\": 30664000000.0, \"gross_profit_fmt\": \"\u00a5307\u5104\", \"operating_income\": 6500000000.0, \"operating_income_fmt\": \"\u00a565\u5104\", \"ebit\": 9902000000.0, \"ebit_fmt\": \"\u00a599\u5104\", \"net_income\": 7545000000.0, \"net_income_fmt\": \"\u00a575\u5104\", \"eps\": 266.51, \"operating_margin\": 10.34, \"total_assets\": 90745000000.0, \"total_assets_fmt\": \"\u00a5907\u5104\", \"total_equity\": 61929000000.0, \"total_equity_fmt\": \"\u00a5619\u5104\", \"total_debt\": 9485000000.0, \"total_debt_fmt\": \"\u00a595\u5104\", \"total_cash\": 13738000000.0, \"total_cash_fmt\": \"\u00a5137\u5104\", \"equity_ratio\": 68.25, \"de_ratio\": 0.15, \"current_ratio\": 2.34, \"operating_cf\": 1486000000.0, \"operating_cf_fmt\": \"\u00a515\u5104\", \"investing_cf\": 1706000000.0, \"investing_cf_fmt\": \"\u00a517\u5104\", \"financing_cf\": -3943000000.0, \"financing_cf_fmt\": \"-\u00a539\u5104\", \"free_cf\": 33000000.0, \"free_cf_fmt\": \"\u00a533.0M\", \"net_margin\": 12.01, \"roe\": 12.18, \"roa\": 8.31}, {\"year\": 2023, \"revenue\": 60461000000.0, \"revenue_fmt\": \"\u00a5605\u5104\", \"gross_profit\": 28584000000.0, \"gross_profit_fmt\": \"\u00a5286\u5104\", \"operating_income\": 5108000000.0, \"operating_income_fmt\": \"\u00a551\u5104\", \"ebit\": 5407000000.0, \"ebit_fmt\": \"\u00a554\u5104\", \"net_income\": 4238000000.0, \"net_income_fmt\": \"\u00a542\u5104\", \"eps\": 150.08, \"operating_margin\": 8.45, \"total_assets\": 87138000000.0, \"total_assets_fmt\": \"\u00a5871\u5104\", \"total_equity\": 54531000000.0, \"total_equity_fmt\": \"\u00a5545\u5104\", \"total_debt\": 12623000000.0, \"total_debt_fmt\": \"\u00a5126\u5104\", \"total_cash\": 14505000000.0, \"total_cash_fmt\": \"\u00a5145\u5104\", \"equity_ratio\": 62.58, \"de_ratio\": 0.23, \"current_ratio\": 3.05, \"operating_cf\": 3351000000.0, \"operating_cf_fmt\": \"\u00a534\u5104\", \"investing_cf\": -1126000000.0, \"investing_cf_fmt\": \"-\u00a511\u5104\", \"financing_cf\": -1820000000.0, \"financing_cf_fmt\": \"-\u00a518\u5104\", \"free_cf\": 2605000000.0, \"free_cf_fmt\": \"\u00a526\u5104\", \"net_margin\": 7.01, \"roe\": 7.77, \"roa\": 4.86}], \"has_data\": true}, \"dividends\": {\"history\": [{\"year\": 2022, \"amount\": 16.0}, {\"year\": 2023, \"amount\": 28.0}, {\"year\": 2024, \"amount\": 45.0}, {\"year\": 2025, \"amount\": 57.0}, {\"year\": 2026, \"amount\": 33.0}], \"latest\": 33.0, \"has_data\": true}}","ma_5_value":0,"ma_5_deviation":0,"ma_5_trend":"","ma_25_value":0,"ma_25_deviation":0,"ma_25_trend":"","ma_75_value":0,"ma_75_deviation":0,"ma_75_trend":"","ma_200_value":0,"ma_200_deviation":0,"ma_200_trend":"","previousClose":0,"open":0,"dayHigh":0,"dayLow":0,"volume":0,"averageVolume":0,"revenueGrowth":0},"sector":[],"class_list":["post-17164","company","type-company","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ASKA PHARMACEUTICAL HOLDINGS CO - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4886\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4886\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4886\/\",\"name\":\"ASKA PHARMACEUTICAL HOLDINGS CO - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-01-11T13:36:04+00:00\",\"dateModified\":\"2026-08-23T04:40:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4886\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4886\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4886\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ASKA PHARMACEUTICAL HOLDINGS CO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ASKA PHARMACEUTICAL HOLDINGS CO - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4886\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4886\/","url":"https:\/\/japanir.jp\/en\/company\/company-4886\/","name":"ASKA PHARMACEUTICAL HOLDINGS CO - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-01-11T13:36:04+00:00","dateModified":"2026-08-23T04:40:38+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4886\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4886\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4886\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"ASKA PHARMACEUTICAL HOLDINGS CO"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company\/17164","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/company"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=17164"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=17164"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}